GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
Z19.1
Hormone sensitive malignancy status
ICD10CM code
Medical Policies and Guidelines for Hormone sensitive malignancy status
Related policies from health plans
ANTHEM-BLUECROSS-CA
Gamma Glutamyl Transferase Testing
ANTHEM-BLUECROSS-CA
Outpatient Laboratory-based Blood Glucose Testing
ANTHEM-BLUECROSS-CA
Outpatient Urine Culture
ANTHEM-BLUECROSS-CA
Thyroid Testing
ANTHEM-BLUECROSS-CT
CG-LAB-20 Thyroid Testing
ANTHEM-BLUECROSS-CT
CG-LAB-24 Outpatient Urine Culture
ANTHEM-BLUECROSS-CT
CG-LAB-29 Gamma Glutamyl Transferase Testing
ANTHEM-BLUECROSS-CT
CG-LAB-30 Outpatient Laboratory-based Blood Glucose Testing
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
Z19.1
- Hormone sensitive malignancy status
Z19
- Hormone sensitivity malignancy status
Z19.2
- Hormone resistant malignancy status
Z17
- Estrogen receptor status
Z85
- Personal history of malignant neoplasm
Z85.85
- Personal history of malignant neoplasm of endocrine glands
Z85.9
- Personal history of malignant neoplasm, unspecified
Z85.3
- Personal history of malignant neoplasm of breast
Z12.3
- Encounter for screening for malignant neoplasm of breast
Z15.0
- Genetic susceptibility to malignant neoplasm
HCPCS codes
G9842
- Patient has metastatic disease at diagnosis
G9097
- Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as
G8875
- Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G9552
- Incidental thyroid nodule < 1.0 cm noted in report
D7430
- Excision of benign tumor-lesion diameter up to 1.25 cm
G8721
- Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documente
D0190
- Screening of a patient
G9618
- Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial
D0191
- Assessment of a patient
G9549
- Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadeno
CPT4 codes
3374F
- AJCC Breast Cancer Stage I: T1c (tumor size > 1 cm to 2 cm) documented (ONC)
3344F
- Mammogram assessment category of suspicious, documented (RAD)
3315F
- Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)
81500
- Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menop
3316F
- Estrogen receptor (ER) and progesterone receptor (PR) negative breast cancer (ONC)
3342F
- Mammogram assessment category of benign, documented (RAD)
3388F
- AJCC colon cancer, Stage III documented (ONC)
58956
- Bilateral salpingo-oophorectomy with total omentectomy, total abdominal hysterectomy for malignancy
0045U
- Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 1
1150F
- Documentation that a patient has a substantial risk of death within 1 year (Pall Cr)